<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>APPROVED</status><version>v2</version><patient-age>17</patient-age><report-id>US-ELI_LILLY_AND_COMPANY-US201211000201</report-id><gender>male</gender><reactions><reaction>left knee buckled requiring ACL repair/ ACL tear</reaction><reaction>blood sugar raised</reaction><reaction>new vial of Humalog is not controlling blood sugars</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>HUMALOG LISPRO</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>LEVOTHYROXINE</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Type 1 diabetes mellitus</indication><indication>Hypothyroidism</indication></indications><patient-age>17</patient-age><outcomes/><country>United States</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>734881_111</messagenumb>
		<messagesenderidentifier>LILLYFDA</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20130125151007</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>2</safetyreportversion>
		<safetyreportid>US-ELI_LILLY_AND_COMPANY-US201211000201</safetyreportid>
		<primarysourcecountry>US</primarysourcecountry>
		<occurcountry>US</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2013-01-17</transmissiondate>
		<reporttype>1</reporttype>
		<serious code="1">Yes</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>2</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>1</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2012-10-30</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2013-01-14</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>US-ELI_LILLY_AND_COMPANY-US201211000201</companynumb>
		<medicallyconfirm>1</medicallyconfirm>
		<primarysource>
			<reportertitle>Ms.</reportertitle>
			<reportergivename>Karen</reportergivename>
			<reporterfamilyname>Arnison</reporterfamilyname>
			<reporterstreet>105 East Chancelor Street</reporterstreet>
			<reportercity>Arligton</reportercity>
			<reporterstate>MN</reporterstate>
			<reporterpostcode>55307</reporterpostcode>
			<reportercountry>US</reportercountry>
			<qualification code="5">Consumer or non-health professional</qualification>
		</primarysource>
		<primarysource>
			<reportergivename>Erin</reportergivename>
			<reporterfamilyname>Maguire</reporterfamilyname>
			<reportercountry>US</reportercountry>
			<qualification code="3">Other Health Professional</qualification>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>Eli Lilly and Company</senderorganization>
			<senderdepartment>BS200</senderdepartment>
			<sendertitle>Mr.</sendertitle>
			<sendergivename>John</sendergivename>
			<sendermiddlename>A.</sendermiddlename>
			<senderfamilyname>Fredenburg</senderfamilyname>
			<senderstreetaddress>Lilly Corporate Center</senderstreetaddress>
			<sendercity>Indianapolis</sendercity>
			<senderstate>IN</senderstate>
			<senderpostcode>46285</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>2770207</sendertel>
			<sendertelcountrycode>317</sendertelcountrycode>
			<senderfax>8666441697</senderfax>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>Food and Drug Administration - CDER</receiverorganization>
			<receiverdepartment>Office of Surveillance and Epidemiology</receiverdepartment>
			<receivertitle>Mr</receivertitle>
			<receivergivename>Roger</receivergivename>
			<receiverfamilyname>Goetsch</receiverfamilyname>
			<receiverstreetaddress>12300 TwinbrookParkway, Suite 240</receiverstreetaddress>
			<receivercity>Rockville</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20851</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>3017709299</receivertel>
			<receivertelcountrycode>001</receivertelcountrycode>
			<receiverfax>3017706614</receiverfax>
			<receiverfaxcountrycode>001</receiverfaxcountrycode>
			<receiveremailaddress>roger.goetsch@fda.hhs.gov</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>AS</patientinitial>
			<patientonsetage>17</patientonsetage>
			<patientonsetageunit>801</patientonsetageunit>
			<patientweight>64.853</patientweight>
			<patientsex code="1">Male</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Hypothyroidism</patientepisodename>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>left knee buckled requiring ACL repair/ ACL tear</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Anterior cruciate ligament tear</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Ligament rupture</reactionmeddrapt>
				<termhighlighted>4</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20120921</reactionstartdate>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>blood sugar raised</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Blood sugar increased</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Blood glucose increased</reactionmeddrapt>
				<termhighlighted>2</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20121030</reactionstartdate>
				<reactionenddateformat>102</reactionenddateformat>
				<reactionenddate>20121030</reactionenddate>
				<reactionduration>1</reactionduration>
				<reactiondurationunit>804</reactiondurationunit>
				<reactionfirsttime>1</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>new vial of Humalog is not controlling blood sugars</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Lack of drug effect</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Drug ineffective</reactionmeddrapt>
				<termhighlighted>2</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20121030</reactionstartdate>
				<reactionenddateformat>102</reactionenddateformat>
				<reactionenddate>20121030</reactionenddate>
				<reactionduration>1</reactionduration>
				<reactiondurationunit>804</reactiondurationunit>
				<reactionfirsttime>1</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20121030</testdate>
				<testname>Blood glucose</testname>
				<testresult>260</testresult>
				<testunit>mg/dl</testunit>
				<hightestrange>130</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20121030</testdate>
				<testname>Blood glucose</testname>
				<testresult>258</testresult>
				<testunit>mg/dl</testunit>
				<hightestrange>130</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20121030</testdate>
				<testname>Blood glucose</testname>
				<testresult>290</testresult>
				<testunit>mg/dl</testunit>
				<hightestrange>130</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20121030</testdate>
				<testname>Blood glucose</testname>
				<testresult>90</testresult>
				<testunit>mg/dl</testunit>
				<hightestrange>130</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>HUMALOG LISPRO</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugbatchnumb>A967482A</drugbatchnumb>
				<drugauthorizationnumb>20-563</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>Eli Lilly and Company</drugauthorizationholder>
				<drugdosagetext>UNK, prn</drugdosagetext>
				<drugdosageform normalized="injection">Injection</drugdosageform>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Type 1 diabetes mellitus</drugindication>
				<drugstartdateformat>602</drugstartdateformat>
				<drugstartdate>2008</drugstartdate>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2012-10-30</drugenddate>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>INSULIN, LISPRO</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Blood glucose increased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Reported</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Blood glucose increased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Reported</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Drug ineffective</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Reported</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Drug ineffective</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Reported</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Ligament rupture</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Reported</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Ligament rupture</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Reported</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>HUMALOG LISPRO</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugbatchnumb>A907650F</drugbatchnumb>
				<drugauthorizationnumb>20-563</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>Eli Lilly and Company</drugauthorizationholder>
				<drugdosagetext>UNK, prn</drugdosagetext>
				<drugdosageform normalized="injection">Injection</drugdosageform>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2012-10-30</drugstartdate>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>INSULIN, LISPRO</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Blood glucose increased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Reported</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Blood glucose increased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Reported</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Drug ineffective</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Reported</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Drug ineffective</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Reported</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Ligament rupture</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Reported</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Ligament rupture</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Reported</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>LEVOTHYROXINE</medicinalproduct>
				<drugstructuredosagenumb>50</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>50 mg, UNK</drugdosagetext>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Hypothyroidism</drugindication>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>LEVOTHYROXINE</activesubstancename>
				</activesubstance>
			</drug>
			<summary>
				<narrativeincludeclinical>This spontaneous case, reported by a consumer with additional information provided by a <Semaphore x="2398421" class="Occupation" value="Physician Assistant" score="1.00" ID="C53423">physician assistant </Semaphore>who <Semaphore x="1802982" class="Disease or Finding" value="Communication Disorder" score="1.00" ID="C2958">contacted </Semaphore>the company to report a <Semaphore x="3204997" class="MedDRA LLT" value="Product quality issue" score="1.00" ID="10069327">product complaint</Semaphore>, <Semaphore x="1805433" class="Procedure" value="Concern About Finances" score="1.00" ID="C104604">concerns </Semaphore>a <Semaphore x="1387834" class="Patient Age" value="17" score="1.00" ID=""><Semaphore x="5960701642276865" class="Patient Age" value="17" score="1.00" ID="">17 </Semaphore>year old </Semaphore>male patient of unknown origin.Medical history included <Semaphore x="2042024" class="Disease or Finding" value="Hypothyroidism" score="1.00" ID="C26800">hypothyroidism</Semaphore>. Concomitant medications included levothyroxine.The patient received <Semaphore x="730644" class="Medicine" value="Insulin Lispro" score="0.98" ID="290552"><Semaphore x="2809836" class="MedDRA LLT" value="Blood insulin" score="1.00" ID="10005605">insulin </Semaphore>lispro </Semaphore>(<Semaphore x="669768" class="Medicine" value="Humalog" score="0.49" ID="228096">Humalog</Semaphore>; vial) at an unknown daily dose on a sliding <Semaphore x="2497356" class="AnatomicStructure" value="Scalene Lymph Node" score="1.00" ID="C89780">scale </Semaphore><Semaphore x="187403" class="Medicine" value="Basis" score="0.49" ID="189629">basis </Semaphore>for the <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>of <Semaphore x="2659346" class="Disease or Finding" value="Type 1 Diabetes Mellitus" score="1.00" ID="C2986">type 1 <Semaphore x="2904422" class="MedDRA LLT" value="Diabetes mellitus" score="1.00" ID="10012601">diabetes </Semaphore></Semaphore>beginning on an unknown date in 2008, reported as about four years ago from the time of the report (30Oct2012). On 21Sep2012, while receiving <Semaphore x="730644" class="Medicine" value="Insulin Lispro" score="0.98" ID="290552"><Semaphore x="2809836" class="MedDRA LLT" value="Blood insulin" score="1.00" ID="10005605">insulin </Semaphore>lispro</Semaphore>, the patients left <Semaphore x="2089953" class="AnatomicStructure" value="Knee Joint" score="1.00" ID="C32898">knee </Semaphore>buckled during football resulting in an <Semaphore x="3068079" class="MedDRA LLT" value="Ligament rupture" score="1.00" ID="10065433"><Semaphore x="1529314" class="AnatomicStructure" value="Anterior Cruciate Ligament" score="1.00" ID="C32088">anterior cruciate <Semaphore x="2111727" class="AnatomicStructure" value="Ligament" score="1.00" ID="C13046">ligament </Semaphore></Semaphore>(ACL) <Semaphore x="2604534" class="Disease or Finding" value="Tearing" score="1.00" ID="C38031">tear</Semaphore></Semaphore>. The event was considered serious by the company for medical <Semaphore x="2521236" class="Disease or Finding" value="Significant Arterial Dissection" score="1.00" ID="C99709">significance</Semaphore>. On 26Oct2012, the patient underwent same day <Semaphore x="2596409" class="Procedure" value="Surgical Procedure" score="1.00" ID="C15329">surgery </Semaphore>for left ACL <Semaphore x="2447540" class="Procedure" value="Reconstructive Surgery" score="1.00" ID="C25351">reconstruction </Semaphore>and treated post operatively with <Semaphore x="394948" class="Medicine" value="Codeine Phosphate" score="0.49" ID="252252">codeine <Semaphore x="2396146" class="Procedure" value="Phosphate Measurement" score="1.00" ID="C64857">phosphate</Semaphore></Semaphore>,<Semaphore x="2737985" class="MedDRA LLT" value="Analgesic drug level" score="1.00" ID="10060090">paracetamol</Semaphore>. No laboratory/diagnostic <Semaphore x="1910095" class="Disease or Finding" value="Experimental Result" score="1.00" ID="C76125">results</Semaphore>, additional <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>measures or further information regarding the event was provided. On 30Oct2012, the patient opened a new vial of <Semaphore x="730644" class="Medicine" value="Insulin Lispro" score="0.98" ID="290552"><Semaphore x="2809836" class="MedDRA LLT" value="Blood insulin" score="1.00" ID="10005605">insulin </Semaphore>lispro </Semaphore>(lot: A967482A) and experienced a <Semaphore x="2806733" class="MedDRA LLT" value="Blood glucose increased" score="1.00" ID="10005557">high <Semaphore x="2806860" class="MedDRA LLT" value="Blood glucose" score="1.00" ID="10005553">blood <Semaphore x="627832" class="Medicine" value="Glucose" score="0.74" ID="269493">glucose </Semaphore></Semaphore></Semaphore>reading of 260 mg/dl (normal for the patient: 130 mg/dl). As <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment</Semaphore>, the patient injected a correction dose of 8 units from the same vial and his <Semaphore x="1608509" class="AnatomicStructure" value="Blood" score="1.00" ID="C12434">blood </Semaphore>sugar was 258 mg/dl. One hour following the correction dose of 8 units, the patients <Semaphore x="1608509" class="AnatomicStructure" value="Blood" score="1.00" ID="C12434">blood </Semaphore><Semaphore x="627832" class="Medicine" value="Glucose" score="0.74" ID="269493">glucose </Semaphore>was still raised at 290 mg/dl. It was reported that this new vial of <Semaphore x="730644" class="Medicine" value="Insulin Lispro" score="0.98" ID="290552"><Semaphore x="2809836" class="MedDRA LLT" value="Blood insulin" score="1.00" ID="10005605">insulin </Semaphore>lispro </Semaphore>(lot: A967482A) was not <Semaphore x="1854518" class="Disease or Finding" value="Disease Controlled" score="1.00" ID="C82500">controlling </Semaphore>the patients <Semaphore x="1608509" class="AnatomicStructure" value="Blood" score="1.00" ID="C12434">blood </Semaphore>sugars (<Semaphore x="2914105" class="MedDRA LLT" value="Drug ineffective" score="1.00" ID="10013709">lack of <Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">drug </Semaphore>effect</Semaphore>). Later that same day, the patient opened a new vial of <Semaphore x="730644" class="Medicine" value="Insulin Lispro" score="0.98" ID="290552"><Semaphore x="2809836" class="MedDRA LLT" value="Blood insulin" score="1.00" ID="10005605">insulin </Semaphore>lispro </Semaphore>from a different lot (A907650F) and injected, which brought him down to 90. The <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>of left <Semaphore x="2089953" class="AnatomicStructure" value="Knee Joint" score="1.00" ID="C32898">knee </Semaphore>buckled requiring ACL repair was recovering while the <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>of the remaining events was recovered. <Semaphore x="730644" class="Medicine" value="Insulin Lispro" score="0.98" ID="290552"><Semaphore x="2809836" class="MedDRA LLT" value="Blood insulin" score="1.00" ID="10005605">Insulin </Semaphore>lispro </Semaphore><Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">therapy </Semaphore>was continued.The reporting <Semaphore x="2398421" class="Occupation" value="Physician Assistant" score="1.00" ID="C53423">physician assistant </Semaphore>did not provide an opinion of relatedness.Update 15Jan2013: Additional information was received on 14Jan2013 as requested by the company. Added <Semaphore x="2398421" class="Occupation" value="Physician Assistant" score="1.00" ID="C53423">physician assistant </Semaphore>reporter <Semaphore x="1802982" class="Disease or Finding" value="Communication Disorder" score="1.00" ID="C2958">contact </Semaphore>information, medical history, patient <Semaphore x="3320545" class="MedDRA LLT" value="Weight" score="1.00" ID="10047890">weight</Semaphore>, date of left <Semaphore x="2089939" class="Disease or Finding" value="Knee Injury" score="1.00" ID="C34753">knee injury</Semaphore>, concomitant and <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>medications. Updated causality and the narrative with the new information.</narrativeincludeclinical>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>